FindMyKOL

Farhat Khairallah, MD

Basic profile

Tallahassee Memorial HealthCare

ORCIDNone on fileNPIOn fileSign in to see identifiers
✓ Itemized record
RegionTallahassee, FL · SoutheastSpecialtyClinical Cardiac ElectrophysiologyFocusCardiology
Active KOLFindMyKOL type: RegionalLatest publicationSee ScholarshipOnline presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Farhat Khairallah is a Cardiology physician affiliated with Tallahassee Memorial HealthCare. OpenAlex indexes 8 publications with 487 citations (h-index 5); ClinicalTrials.gov lists 1 registered study matched to this name.

Overview

Scholarship

indexed output and impact (OpenAlex)
8publications

Publications indexed by OpenAlex. Counts exclude supporting files.

487citations

Citations across these publications.

5h-index

H-index from these publications.

Clinical & industry

trials, payments and federal funding
1clinical trials

Investigator role on registered studies.

View trials ↓
32companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Clinical trials

Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.

Industry payments

32 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

  • Boston Scientific Corporation
    Program year2025117 payments
    $95,545
  • Ethicon US, LLC
    Program year20257 payments
    $4,485
  • Abbott Laboratories
    Program year202528 payments
    $2,737
All 71 payment records: search, sort and filter.Explore →

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    52.2%
    Beta blocker29.6%
    Metoprolol Succinate69%Metoprolol Tartrate11%Carvedilol8%Sotalol8%Propranolol Hcl2%Atenolol1%Nebivolol Hcl1%
    Part D<11 patients
    Antiarrhythmic7%
    Amiodarone Hcl63%Dofetilide26%Flecainide Acetate11%
    Part D≥88 patients

    + 13 more classes in this area

  • Blood & clotting

    42.4%
    Factor Xa inhibitor38%
    Eliquis83%Xarelto17%
    Part D≥375 patients
    P2Y12 inhibitor1.8%
    Clopidogrel100%
    Part D≥42 patients

    + 2 more classes in this area

  • Metabolism & gastrointestinal

    3.4%
    Proton pump inhibitor1.6%
    Pantoprazole Sodium100%
    Part D≥53 patients
    Potassium supplement1.4%
    Potassium Chloride100%
    Part D≥30 patients

    + 1 more class in this area

Where care is delivered (Part B)26.8% facility · 73.2% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”